Literature DB >> 2924616

Noninvasive face mask ventilation in patients with acute respiratory failure.

G U Meduri1, C C Conoscenti, P Menashe, S Nair.   

Abstract

Noninvasive face mask ventilation has been used successfully in patients with paralytic respiratory failure. This study evaluated whether noninvasive face mask ventilation can be used for patients with acute respiratory failure due to intrinsic lung disease. Six patients with hypercapnia and four with hypoxemic acute respiratory failure met clinical and objective criteria for mechanical ventilation, which was delivered with pressure control and pressure support via a tightly strapped, clear face mask. No patient terminated the study because of inability to deliver adequate ventilation or to improve oxygen exchange; three eventually required endotracheal intubation. The mask was generally well tolerated. All patients had a nasogastric tube placed on suction, and none vomited or aspirated. The mean duration of treatment was 33 h (range, 3 to 88). The physiologic response was considered similar to that which would have been achieved with conventionally delivered ventilation. Noninvasive face mask ventilation may have a role in managing respiratory failure.

Entities:  

Mesh:

Year:  1989        PMID: 2924616     DOI: 10.1378/chest.95.4.865

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  37 in total

1.  Non-invasive ventilation in acute respiratory failure.

Authors: 
Journal:  Thorax       Date:  2002-03       Impact factor: 9.139

2.  [Noninvasive ventilation in acute respiratory insufficiency].

Authors:  C G Cornelissen; M Dreher
Journal:  Med Klin Intensivmed Notfmed       Date:  2018-01-08       Impact factor: 0.840

3.  Defining, treating and preventing hospital acquired pneumonia: European perspective.

Authors:  Antoni Torres; Santiago Ewig; Harmut Lode; Jean Carlet
Journal:  Intensive Care Med       Date:  2008-11-07       Impact factor: 17.440

Review 4.  [Hypercapnic respiratory failure. Pathophysiology, indications for mechanical ventilation and management].

Authors:  U Kreppein; P Litterst; M Westhoff
Journal:  Med Klin Intensivmed Notfmed       Date:  2016-02-22       Impact factor: 0.840

5.  Clinical practice guidelines for the use of noninvasive positive-pressure ventilation and noninvasive continuous positive airway pressure in the acute care setting.

Authors:  Sean P Keenan; Tasnim Sinuff; Karen E A Burns; John Muscedere; Jim Kutsogiannis; Sangeeta Mehta; Deborah J Cook; Najib Ayas; Neill K J Adhikari; Lori Hand; Damon C Scales; Rose Pagnotta; Lynda Lazosky; Graeme Rocker; Sandra Dial; Kevin Laupland; Kevin Sanders; Peter Dodek
Journal:  CMAJ       Date:  2011-02-14       Impact factor: 8.262

Review 6.  Non-invasive ventilation for exacerbations of respiratory failure in chronic obstructive pulmonary disease.

Authors:  J A Wedzicha
Journal:  Thorax       Date:  1996-08       Impact factor: 9.139

Review 7.  Non-invasive ventilation for the management of acute hypercapnic respiratory failure due to exacerbation of chronic obstructive pulmonary disease.

Authors:  Christian R Osadnik; Vanessa S Tee; Kristin V Carson-Chahhoud; Joanna Picot; Jadwiga A Wedzicha; Brian J Smith
Journal:  Cochrane Database Syst Rev       Date:  2017-07-13

8.  Length of ICU stay for chronic obstructive pulmonary disease varies among large community hospitals.

Authors:  Sean P Keenan; Peter Dodek; Keith Chan; Robert S Hogg; Kevin J P Craib; Aslam H Anis; John J Spinelli
Journal:  Intensive Care Med       Date:  2003-03-15       Impact factor: 17.440

9.  Pressure support ventilation via face mask in acute respiratory failure in hypercapnic COPD patients.

Authors:  R Fernandez; L Blanch; J Valles; F Baigorri; A Artigas
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

10.  [Non-invasive ventilation as treatment for acute respiratory insufficiency. Essentials from the new S3 guidelines].

Authors:  B Schönhofer; R Kuhlen; P Neumann; M Westhoff; C Berndt; H Sitter
Journal:  Anaesthesist       Date:  2008-11       Impact factor: 1.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.